Found 15 matching trials
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection N/A This is a retrospective case:control study examining the use of adjunctive ...
Show More Location
Loyola University Medical Center
Learn More & Join Trial
Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection N/A The goal is to evaluate the benefit of adding bezlotoxumab to repeat fecal ...
Show More Location
University of Minnesota
Learn More & Join Trial
Addressing Personalized Needs in Clostridioides Difficile Infection NA BEYOND is aiming to demonstrate how by enrichment of the available SPECIFY ...
Show More Location
4th Department of Internal Medicine, ATTIKON University General Hospital
Learn More & Join Trial
Bezlotoxumab Efficacy and Tolerability in Cancer Patient PHASE4 Investigation of efficacy and tolerability of bezlotoxumab in patients with...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery. PHASE4 A new medication, Bezlotoxumab, has been approved for treatment of recurren...
Show More Location
The Ohio State University
Learn More & Join Trial
Bezlotoxumab Versus FMT for Multiple Recurrent CDI PHASE4 The objective of this trial is to investigate whether a treatment strategy ...
Show More Location
Amsterdam University Medical Centers, AMC
Learn More & Join Trial
A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) PHASE3 MK-3415A is the combination of monoclonal antibodies to Clostridium (C.) di...
Show More Location
Multiple Locations
Learn More & Join Trial
Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection PHASE4 This is a research study to collect information from people that have Clost...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) PHASE3 The primary objectives of this study are to evaluate the pharmacokinetics (...
Show More Location
Children's Hospital - Los Angeles ( Site 0021)
Learn More & Join Trial
Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection PHASE2 Previous data have shown that integrated information from single nucleotide...
Show More Location
2nd Department of Internal Medicine, University General Hospital of Alexandroupolis
Learn More & Join Trial